Trist, David
GlaxoSmithKline (Italy)
3 papers on CoChat
Most cited papers
- Verified
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies
Ratti, E., Bettica, P., Alexander, R., Archer, G., Carpenter, D., Evoniuk, G., Gomeni, R., Lawson, E., Lopez, M., Millns, H., et al. (2013) · Journal of Psychopharmacology
Treatment of Major DepressionNeuropeptides and Animal Physiology
Cited by 69
- Verified
Differential Effects of the CRF-R1 Antagonist GSK876008 on Fear-Potentiated, Light- and CRF-Enhanced Startle Suggest Preferential Involvement in Sustained vs Phasic Threat Responses
Walker, D., Yang, Y., Ratti, E., Corsi, M., Trist, D., & Davis, M. (2009) · Neuropsychopharmacology
Memory and Neural MechanismsNeuropeptides and Animal Physiology
Cited by 69
- Verified
Synthesis and Pharmacological Characterization of Novel Druglike Corticotropin-Releasing Factor 1 Antagonists
Fabio, R. D., St-Denis, Y., Sabbatini, F. M., Andreotti, D., Arban, R., Bernasconi, G., Braggio, S., Blaney, F. E., Capelli, A. M., Castiglioni, E., et al. (2008) · Journal of Medicinal Chemistry
Heterocyclic Compound Synthesis and BioactivityNeuropeptides and Animal Physiology
Cited by 34
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free